Strive Asset Management LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Strive Asset Management LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 799 shares of the healthcare conglomerate’s stock, valued at approximately $404,000.

Other large investors have also modified their holdings of the company. Waycross Partners LLC lifted its holdings in UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after buying an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $515,000. Full Sail Capital LLC grew its stake in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Lmcg Investments LLC raised its position in UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after purchasing an additional 4,022 shares in the last quarter. Finally, Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $39,413,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $291.24 on Friday. The business has a fifty day simple moving average of $470.82 and a 200 day simple moving average of $513.60. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm has a market cap of $264.20 billion, a price-to-earnings ratio of 18.79, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the firm posted $6.91 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.88%. UnitedHealth Group’s dividend payout ratio is 35.18%.

Analyst Ratings Changes

Several research analysts have commented on the stock. Robert W. Baird lowered their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a report on Wednesday. Raymond James lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday. Morgan Stanley lowered their price objective on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 22nd. Six analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $486.00.

Insider Activity

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the firm’s stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John F. Rex purchased 17,175 shares of the company’s stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.